Only bold reform will expand access to innovative medicines in the UK
Greater collaboration between industry, government, policymakers and the NHS will be critical for treatment options in the UK to match the pace of scientific innovation. What is our route to achieving timely patient access across the country like our European neighbours?
Tomas Kauer - Moderator 
Greater collaboration between industry, government, policymakers and the NHS will be critical for treatment options in the UK to match the pace of scientific innovation. What is our route to achieving timely patient access across the country like our European neighbours?
